Myeloma Patients Europe (MPE) will present as part of the Patient Advocacy Track at the European Society for Medical Oncology (ESMO) Annual Congress. The Congress will be held from 20 to 24 October in Madrid, Spain where the latest data in oncology research and development will be presented.
Kate Morgan, MPE Co-Chief Executive Officer, and Lise-lott Eriksson, MPE Board President, will each give a talk during the patient advocacy session, “How to improve access to medicines through patient engagement?” Lise-lott Eriksson’s talk will address “Patient engagement and collaboration with national regulatory agencies” and Kate Morgan will present “A gap analysis on access to modern medicines and treatments: A comparison between West and Eastern Europe”.
ESMO’s Patient Advocacy Track is designed to deepen patient advocates’ knowledge about a range of issues that can directly impact on the patients and their families, as well as organisations’ advocacy efforts. This track will cover topics including improving access to medicines through patient engagement, caregivers’ needs, new digital solutions for patients and the importance of secondary prevention, among others. View the full Patient Advocacy Track programme here.
Keep an eye out on MPE social media profiles for updates throughout the congress.